MRTX

Mirati Therapeutics, Inc. Common Stock

Delisted

MRTX was delisted on the 22nd of January, 2024.

58 hedge funds and large institutions have $319M invested in Mirati Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$32.6M
2 +$12.5M
3 +$9.41M
4
TCM
Tang Capital Management
California
+$4.4M
5
BC
Broadfin Capital
New York
+$3.57M

Top Sellers

1 -$1.49M
2 -$1.16M
3 -$526K
4
Goldman Sachs
Goldman Sachs
New York
-$506K
5
JP Morgan Chase
JP Morgan Chase
New York
-$102K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$801K
27
$733K
28
$733K
29
$725K
30
$712K
31
$701K
32
$666K
33
$581K
34
$520K
35
$493K
36
$484K
37
$458K
38
$349K
39
$335K
40
$327K
41
$308K
42
$261K
43
$215K
44
$160K
45
$147K
46
$132K
47
$121K
48
$69K
49
$44K
50
$13K